Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-03-31 to 2022-04-21
Current total value of award: $2272.4
Description: 4556822533!OMIDRIA 1-0.3% VIAL 4ML